Oct 6 (Reuters) - Algen Biotechnologies said on Monday it had agreed to grant AstraZeneca (AZN.L), opens new tab a license to develop therapies the U.S.-based biotech discover using its AI-driven gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback